Amgen Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Amgen Inc.

Amgen Inc. | Ownership

Companies that own Amgen Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Fidelity Management & Research Co.

68,638,064

10.6%

27,561,766

1.39%

06/30/2018

The Vanguard Group, Inc.

48,316,614

7.47%

289,533

0.31%

06/30/2018

Capital Research & Management Co. (Global Investors)

45,938,476

7.1%

-1,096,159

1.67%

06/30/2018

BlackRock Fund Advisors

32,381,233

-2,318,069

0.32%

06/30/2018

SSgA Funds Management, Inc.

26,457,391

4.09%

-1,014,684

0.4%

06/30/2018

PRIMECAP Management Co.

21,173,744

3.27%

-268,600

2.87%

06/30/2018

Northern Trust Investments, Inc.

9,138,352

1.41%

-105,854

0.41%

06/30/2018

Geode Capital Management LLC

8,447,641

1.31%

333,939

0.43%

06/30/2018

Morgan Stanley Smith Barney LLC (Private Banking)

7,267,589

1.12%

-620,963

0.67%

06/30/2018

Norges Bank Investment Management

7,129,137

1.1%

176,162

0.2%

12/31/2017

About Amgen

View Profile

Address	One Amgen Center Drive Thousand Oaks California 91320 United States
Employees	-
Website	http://www.amgen.com
Updated	07/08/2019
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K.